TALPHERA, INC. Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
TALPHERA, INC. (TLPH) reported Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Earnings Per Share › Undistributed Earnings (Loss) Available to Common Shareholders, Diluted
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted · last filed 2023-11-14
- TALPHERA, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2023-09-30 was $0.00.
- TALPHERA, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2022-12-31 was -$748.00K.
- TALPHERA, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2022-09-30 was -$643.00K.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 6 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 9 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2022-12-31 | -$748.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -$1.39M derived: sum of 2 quarters · filed 2023-11-14 | $6.12M derived: sum of 3 quarters · filed 2023-11-14 | $5.23M 8-K · filed 2023-08-01 |
| 2022-09-30 | -$643.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $6.87M derived: sum of 2 quarters · filed 2023-11-14 | $5.97M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $7.51M 10-Q · filed 2023-08-10 | $6.62M 10-Q · filed 2023-08-10 | ||
| 2021-12-31 | $0.00 8-K · filed 2023-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |